Clinical Trial: Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: International Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of the Efficacy and Safety of KIACTA in Preventing Renal Function Decline in Patients With AA Amyloidosi

Brief Summary: The primary purpose of this study is to assess the efficacy and safety of treatment with Kiacta in adult patients with AA Amyloidosis.